Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Investing.com -- Carlsmed, Inc. began trading on the Nasdaq Global Select Market on Wednesday under the ticker symbol "NASDAQ:CARL" at $15 per share, matching the price set in its initial public offering.
The commercial-stage medical technology company, which specializes in AI-enabled personalized spine surgery solutions, priced its IPO at $15.00 per share on Tuesday. The offering included 6,700,000 shares of common stock.
Carlsmed expects to raise approximately $100.5 million in gross proceeds from the offering, before deducting underwriting discounts, commissions, and other offering expenses.
The company has granted the underwriters a 30-day option to purchase up to an additional 1,005,000 shares at the initial public offering price, less underwriting discounts and commissions.
BofA Securities, Goldman Sachs & Co (NYSE:GS). LLC, and Piper Sandler are serving as joint lead book-running managers for the offering, while Truist Securities and BTIG are acting as joint book-runners.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.